Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Damian

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Neurological Disorders|June 28, 2019
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markersOlaf Stuve, Per Soelberg Soerensen, Thomas Leist, et al.
Neurotoxicology and Teratology|August 19, 2004
Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): reproductive performance and birth outcomeThomas M Burbacher, Kimberly S Grant, Danny D Shen, et al.
Drug Safety|May 25, 2020
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of SafetyGavin Giovannoni, Andrew Galazka, Regina Schick, et al.
Neurotoxicology and Teratology|March 17, 2004
Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): exposure and toxicokinetics prior to and during pregnancyThomas M Burbacher, Danny D Shen, Bojan Lalovic, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 21, 2017
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS studyMark S Freedman, Thomas P Leist, Giancarlo Comi, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 15, 2021
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS studyMark S Freedman, Patricia K Coyle, Giancarlo Comi, et al.
Multiple Sclerosis and Related Disorders|February 12, 2021
Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS studyBruce A C Cree, James D Bowen, Hans-Peter Hartung, et al.
Molecular Biosystems|April 26, 2008
Correlation network analysis for data integration and biomarker selectionAram Adourian, Ezra Jennings, Raji Balasubramanian, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Neurological Disorders|June 28, 2019
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markersOlaf Stuve, Per Soelberg Soerensen, Thomas Leist, et al.
Neurotoxicology and Teratology|August 19, 2004
Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): reproductive performance and birth outcomeThomas M Burbacher, Kimberly S Grant, Danny D Shen, et al.
Drug Safety|May 25, 2020
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of SafetyGavin Giovannoni, Andrew Galazka, Regina Schick, et al.
Neurotoxicology and Teratology|March 17, 2004
Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): exposure and toxicokinetics prior to and during pregnancyThomas M Burbacher, Danny D Shen, Bojan Lalovic, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 21, 2017
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS studyMark S Freedman, Thomas P Leist, Giancarlo Comi, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 15, 2021
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS studyMark S Freedman, Patricia K Coyle, Giancarlo Comi, et al.
Multiple Sclerosis and Related Disorders|February 12, 2021
Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS studyBruce A C Cree, James D Bowen, Hans-Peter Hartung, et al.
Molecular Biosystems|April 26, 2008
Correlation network analysis for data integration and biomarker selectionAram Adourian, Ezra Jennings, Raji Balasubramanian, et al.
Pageof 2